Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials

2020 ◽  
Vol 27 (5) ◽  
pp. 497-504 ◽  
Author(s):  
Fred Poordad ◽  
RuiSarmento E. Castro ◽  
Armen Asatryan ◽  
Humberto Aguilar ◽  
Patrice Cacoub ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Safety And Efficacy

scholarly journals Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders

2015 ◽  
Vol 54 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Shinya Watanabe ◽  
Yoshimasa Kobayashi ◽  
Kazuhito Kawata ◽  
Hidenao Noritake ◽  
Takeshi Chida ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interferon Monotherapy

Tu1040 Safety and Efficacy of Sofosbuvir and Simeprevir to Treat Hepatitis C Virus Genotype 1 Infection in Decompensated Cirrhosis

2015 ◽  
Vol 148 (4) ◽  
pp. S-1093
Author(s):  
Whitney E. Jackson ◽  
Ibrahim A. Hanouneh ◽  
Naim Alkhouri ◽  
Rocio Lopez ◽  
Nizar N. Zein ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Decompensated Cirrhosis ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document